Prab: CSV import

2025-03-07T01:40:16Z

CSV import

← Older revision		Revision as of 01:40, 7 March 2025
Line 1:		Line 1:
	~~{{Short description\|A pharmaceutical drug used as a proton pump inhibitor}}~~		== Zastaprazan ==

	'''Zastaprazan''' is a pharmaceutical compound that ~~functions as a~~ [[proton pump ~~inhibitor~~]] (~~PPI~~). It is primarily used in the treatment of conditions related to excessive stomach acid production, such as [[gastroesophageal reflux disease]] (GERD) and [[peptic ulcer disease]].		[[File:Zastaprazan.svg\|Chemical structure of Zastaprazan\|thumb\|right]]

			'''Zastaprazan''' is a pharmaceutical compound that belongs to the class of [[proton pump inhibitors]] (PPIs). It is primarily used in the treatment of conditions related to excessive stomach acid production, such as [[gastroesophageal reflux disease]] (GERD) and [[peptic ulcer disease]].

			== Mechanism of Action ==

	~~==Mechanism of Action==~~		Zastaprazan functions by inhibiting the [[H+/K+ ATPase]] enzyme system, commonly known as the gastric proton pump, located in the parietal cells of the stomach lining. This inhibition prevents the final step of acid production, thereby reducing gastric acidity. By decreasing stomach acid, Zastaprazan helps in alleviating symptoms associated with acid-related disorders and promotes healing of the gastric mucosa.
	Zastaprazan ~~works~~ by inhibiting the [[H+/K+ ATPase]] enzyme system, commonly known as the gastric proton pump, located in the parietal cells of the stomach lining. This inhibition prevents the final step ~~in the production~~ of ~~gastric~~ acid, thereby reducing ~~acid secretion~~. By decreasing stomach ~~acidity~~, Zastaprazan helps in alleviating symptoms associated with acid-related disorders and promotes healing of the gastric mucosa.

	==~~Pharmacokinetics~~==		== Clinical Uses ==
	Zastaprazan is administered orally and is absorbed in the small intestine. It is a prodrug that is activated in the acidic environment of the parietal cells. The drug is metabolized in the liver, primarily by the [[cytochrome P450]] enzyme system, and is excreted through the kidneys.

	~~==Clinical Uses==~~		Zastaprazan is indicated for the management of several gastrointestinal conditions, including:
	Zastaprazan is indicated for the ~~treatment~~ of:
	* [[Gastroesophageal ~~reflux disease]]~~ (GERD)		* '''Gastroesophageal Reflux Disease (GERD):''' A chronic condition where stomach acid frequently flows back into the esophagus, causing irritation.
	* [[~~Peptic ulcer disease~~]]		* '''Peptic Ulcer Disease:''' A condition characterized by sores or ulcers developing in the lining of the stomach or the first part of the small intestine.
	* [[~~Zollinger~~-~~Ellison syndrome~~]]		* '''Zollinger-Ellison Syndrome:''' A rare condition involving tumors in the pancreas or duodenum that cause excessive production of stomach acid.
	* [[~~Erosive esophagitis~~]]
			== Pharmacokinetics ==

			Zastaprazan is administered orally and is absorbed in the small intestine. It undergoes hepatic metabolism primarily via the [[cytochrome P450]] enzyme system. The drug is then excreted through the kidneys. The pharmacokinetic profile of Zastaprazan allows for once-daily dosing, which is convenient for patients.

			== Side Effects ==

			Common side effects of Zastaprazan include headache, nausea, diarrhea, abdominal pain, and dizziness. Long-term use of proton pump inhibitors, including Zastaprazan, has been associated with an increased risk of [[osteoporosis]]-related fractures, [[Clostridium difficile]] infection, and [[hypomagnesemia]].

	==~~Side Effects~~==		== Drug Interactions ==
	Common side effects of Zastaprazan include headache, nausea, diarrhea, abdominal pain, and dizziness. Long-term use of proton pump inhibitors, including Zastaprazan, may be associated with an increased risk of [[osteoporosis]]-related fractures, [[Clostridium difficile]] infection, and [[hypomagnesemia]].

	~~==Drug Interactions==~~		Zastaprazan may interact with other medications metabolized by the cytochrome P450 system, such as [[warfarin]], [[diazepam]], and [[phenytoin]]. It can also affect the absorption of drugs that require an acidic environment for optimal absorption, such as [[ketoconazole]] and [[iron]] supplements.
	Zastaprazan may interact with other medications ~~that are~~ metabolized by the cytochrome P450 system. It can also affect the absorption of drugs that require an acidic environment for optimal absorption, such as [[ketoconazole]] and [[iron]] supplements.

	==~~Development and Approval~~==		== Related Pages ==
	Zastaprazan is developed by pharmaceutical companies focusing on novel treatments for acid-related disorders. It is subject to regulatory approval processes in various countries, where its safety and efficacy are evaluated through clinical trials.

	~~==Related pages==~~
	* [[Proton pump inhibitor]]		* [[Proton pump inhibitor]]
	* [[Gastroesophageal reflux disease]]		* [[Gastroesophageal reflux disease]]
	* [[Peptic ulcer disease]]		* [[Peptic ulcer disease]]
	* [[~~H+/K+ ATPase]]~~		* [[Zollinger-Ellison syndrome]]

	~~[[File:Zastaprazan.svg\|Chemical structure of Zastaprazan\|thumb\|right~~]]

	[[Category:Proton pump inhibitors]]		[[Category:Proton pump inhibitors]]
	[[Category:Gastroenterology]]		[[Category:Gastroenterology]]

Prab: CSV import

2025-03-05T06:15:50Z

CSV import

New page

{{Short description|A pharmaceutical drug used as a proton pump inhibitor}}

'''Zastaprazan''' is a pharmaceutical compound that functions as a [[proton pump inhibitor]] (PPI). It is primarily used in the treatment of conditions related to excessive stomach acid production, such as [[gastroesophageal reflux disease]] (GERD) and [[peptic ulcer disease]].

==Mechanism of Action==
Zastaprazan works by inhibiting the [[H+/K+ ATPase]] enzyme system, commonly known as the gastric proton pump, located in the parietal cells of the stomach lining. This inhibition prevents the final step in the production of gastric acid, thereby reducing acid secretion. By decreasing stomach acidity, Zastaprazan helps in alleviating symptoms associated with acid-related disorders and promotes healing of the gastric mucosa.

==Pharmacokinetics==
Zastaprazan is administered orally and is absorbed in the small intestine. It is a prodrug that is activated in the acidic environment of the parietal cells. The drug is metabolized in the liver, primarily by the [[cytochrome P450]] enzyme system, and is excreted through the kidneys.

==Clinical Uses==
Zastaprazan is indicated for the treatment of:
* [[Gastroesophageal reflux disease]] (GERD)
* [[Peptic ulcer disease]]
* [[Zollinger-Ellison syndrome]]
* [[Erosive esophagitis]]

==Side Effects==
Common side effects of Zastaprazan include headache, nausea, diarrhea, abdominal pain, and dizziness. Long-term use of proton pump inhibitors, including Zastaprazan, may be associated with an increased risk of [[osteoporosis]]-related fractures, [[Clostridium difficile]] infection, and [[hypomagnesemia]].

==Drug Interactions==
Zastaprazan may interact with other medications that are metabolized by the cytochrome P450 system. It can also affect the absorption of drugs that require an acidic environment for optimal absorption, such as [[ketoconazole]] and [[iron]] supplements.

==Development and Approval==
Zastaprazan is developed by pharmaceutical companies focusing on novel treatments for acid-related disorders. It is subject to regulatory approval processes in various countries, where its safety and efficacy are evaluated through clinical trials.

==Related pages==
* [[Proton pump inhibitor]]
* [[Gastroesophageal reflux disease]]
* [[Peptic ulcer disease]]
* [[H+/K+ ATPase]]

[[File:Zastaprazan.svg|Chemical structure of Zastaprazan|thumb|right]]

[[Category:Proton pump inhibitors]]
[[Category:Gastroenterology]]

Zastaprazan - Revision history

Prab: CSV import

Prab: CSV import